ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
20 Mar 2024

Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2)

The Board of directors of Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise period for warrants of seri...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
19 Mar 2024

Acarix receives declarations of intent to exercise warrants of series TO 2

Acarix AB ("Acarix" or the "Company") has received oral declarations of intent to exercise Warrants of series TO 2 (the "Warrants") fro...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
15 Mar 2024

CEO purchases shares in Acarix

New York, New York, March 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Aamir Mahmoo...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
06 Mar 2024

The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today

The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acarix" or the "Com...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
21 Feb 2024

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was passed by th...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
15 Feb 2024

Acarix strengthens US Advisory Board with three industry leaders

New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
November 18, 2024
15 Feb 2024

Acarix AB (publ) publishes Year-End Report 2023

Embarking on a new journey with focus on sustainable growthAs the newly appointed CEO of Acarix, I am honored to be on board and share ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
14 Feb 2024

Invitation to presentation of Acarix´s fourth quarter report

Acarix will publish its fourth quarter results on Thursday 15 February 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (C...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
02 Feb 2024

Acarix CADScor System now listed on US Federal Supply Schedule

Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
01 Feb 2024

NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB

The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, mfn-cus-disclaimer, News, Regulatory, Shares
November 18, 2024
01 Feb 2024

Acarix carries out a directed share issue of approximately SEK 33.7 million

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
01 Feb 2024

Acarix appoints Aamir Mahmood as new CEO

Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia...
Continue reading
  • «
  • ‹
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.